Leveraging Immunocompetent Brain Organoids to Investigate Remyelination & Neuroinflammation
Time: 2:25 pm
day: Day One
Details:
• Developing immunocompetent brain organoids by incorporating iPSC-derived microglia
• Conducting parallel safety and efficacy readouts
• Utilizing brain organoids for biomarker evaluation in drug screening
